{"id":56178,"date":"2001-01-01T00:00:00","date_gmt":"2018-12-04T06:12:23","guid":{"rendered":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/treatment-of-dyslipoproteinemia-in-the-metabolic-syndrome\/"},"modified":"2018-12-04T07:12:23","modified_gmt":"2018-12-04T06:12:23","slug":"treatment-of-dyslipoproteinemia-in-the-metabolic-syndrome","status":"publish","type":"resume","link":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/treatment-of-dyslipoproteinemia-in-the-metabolic-syndrome\/","title":{"rendered":"Treatment of dyslipoproteinemia in the metabolic syndrome"},"content":{"rendered":"<p>The metabolic syndrome consists of a cluster of metabolic disorders, many of which promote the development of atherosclerosis and increase the risk to develop cardiovascular disease. The metabolic syndrome is characterized by atherogenic dyslipidemia (elevated triglycerides. increased small dense low-density lipoproteins. and decreased high-density lipoproteins). hypertension, insulin resistance and obesity. To decrease the risk of cardiovascular disease events decreasing body weight by ingesting a healthy diet. increasing physical activity. cessation of smoking and managing dyslipidemia are recommended. pharmacological treatment of dyslipidemia is based on different drug classes. For LDL-cholesterol-lowering mainly statins and for triglyceride-lowering mainly fibrates are used. In primary and secondary prevention trials of heart disease they have shown to reduce the incidence of coronary artery disease or coronary events by 25-60 percent. Statins reduce mainly LDL-cholesterol levels by competitive inhibition of HMG-CoA reductase but have also shown to reduce fasting and postprandial triglyceride levels. Fibrates effectively reduce fasting and postprandial lipemia, shift the distribution of LDL particles towards less dense particles and increase HDL-cholesterol. Thus fibrates particularly address components of the metabolic syndrome and features of diabetic dyslipidemia. However studies still are needed showing definite evidence on differential therapy in lipid lowering based on prospective controlled trials with endpoints of macro- and microangiopathy in diabetic patients.<\/p>\n","protected":false},"template":"","mots_cles":[],"class_list":["post-56178","resume","type-resume","status-publish","hentry"],"acf":{"adresse":"\"STEINMETZ A,UNIV BONN,TEACHING HOSP ST NIKOLAUS STIFTSHOSP GMBH ANDERNACH;HINDENBURGWALL 1;D-56626 ANDERNACH, GERMANY.\"","annee":"2001","mois":"0","numero":"109:4","page":"548-559","auteurs":[{"ID":56174,"post_author":"0","post_date":"2018-12-04 07:12:19","post_date_gmt":"2018-12-04 06:12:19","post_content":"","post_title":"Fenselau","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"fenselau","to_ping":"","pinged":"","post_modified":"2018-12-04 07:12:19","post_modified_gmt":"2018-12-04 06:12:19","post_content_filtered":"","post_parent":0,"guid":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/auteur\/fenselau\/","menu_order":0,"post_type":"auteur_resume","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":56175,"post_author":"0","post_date":"2018-12-04 07:12:20","post_date_gmt":"2018-12-04 06:12:20","post_content":"","post_title":"Schrezenmeir","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"schrezenmeir","to_ping":"","pinged":"","post_modified":"2018-12-04 07:12:20","post_modified_gmt":"2018-12-04 06:12:20","post_content_filtered":"","post_parent":0,"guid":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/auteur\/schrezenmeir\/","menu_order":0,"post_type":"auteur_resume","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":56176,"post_author":"0","post_date":"2018-12-04 07:12:22","post_date_gmt":"2018-12-04 06:12:22","post_content":"","post_title":"Steinmetz","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"steinmetz","to_ping":"","pinged":"","post_modified":"2018-12-04 07:12:22","post_modified_gmt":"2018-12-04 06:12:22","post_content_filtered":"","post_parent":0,"guid":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/auteur\/steinmetz\/","menu_order":0,"post_type":"auteur_resume","post_mime_type":"","comment_count":"0","filter":"raw"}],"sources":[{"ID":56177,"post_author":"0","post_date":"2018-12-04 07:12:22","post_date_gmt":"2018-12-04 06:12:22","post_content":"","post_title":"EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY &amp; DIABETES","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"experimental-and-clinical-endocrinology-diabetes","to_ping":"","pinged":"","post_modified":"2018-12-04 07:12:22","post_modified_gmt":"2018-12-04 06:12:22","post_content_filtered":"","post_parent":0,"guid":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/source\/experimental-and-clinical-endocrinology-diabetes\/","menu_order":0,"post_type":"source","post_mime_type":"","comment_count":"0","filter":"raw"}]},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v23.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Treatment of dyslipoproteinemia in the metabolic syndrome - Aprifel<\/title>\n<meta name=\"description\" content=\"Treatment of dyslipoproteinemia in the metabolic syndrome - Aprifel\" \/>\n<meta name=\"robots\" content=\"noindex, follow\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Treatment of dyslipoproteinemia in the metabolic syndrome\" \/>\n<meta property=\"og:description\" content=\"Treatment of dyslipoproteinemia in the metabolic syndrome\" \/>\n<meta property=\"og:url\" content=\"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/treatment-of-dyslipoproteinemia-in-the-metabolic-syndrome\/\" \/>\n<meta property=\"og:site_name\" content=\"Aprifel\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/treatment-of-dyslipoproteinemia-in-the-metabolic-syndrome\/\",\"url\":\"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/treatment-of-dyslipoproteinemia-in-the-metabolic-syndrome\/\",\"name\":\"Treatment of dyslipoproteinemia in the metabolic syndrome - Aprifel\",\"isPartOf\":{\"@id\":\"https:\/\/www.aprifel.com\/fr\/#website\"},\"datePublished\":\"2018-12-04T06:12:23+00:00\",\"dateModified\":\"2018-12-04T06:12:23+00:00\",\"description\":\"Treatment of dyslipoproteinemia in the metabolic syndrome - Aprifel\",\"breadcrumb\":{\"@id\":\"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/treatment-of-dyslipoproteinemia-in-the-metabolic-syndrome\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/treatment-of-dyslipoproteinemia-in-the-metabolic-syndrome\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/treatment-of-dyslipoproteinemia-in-the-metabolic-syndrome\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.aprifel.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"R\u00e9sum\u00e9s\",\"item\":\"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Treatment of dyslipoproteinemia in the metabolic syndrome\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.aprifel.com\/fr\/#website\",\"url\":\"https:\/\/www.aprifel.com\/fr\/\",\"name\":\"Aprifel\",\"description\":\"Agence pour la Recherche et l\u2019Information en Fruits et L\u00e9gumes\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.aprifel.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Treatment of dyslipoproteinemia in the metabolic syndrome - Aprifel","description":"Treatment of dyslipoproteinemia in the metabolic syndrome - Aprifel","robots":{"index":"noindex","follow":"follow"},"og_locale":"fr_FR","og_type":"article","og_title":"Treatment of dyslipoproteinemia in the metabolic syndrome","og_description":"Treatment of dyslipoproteinemia in the metabolic syndrome","og_url":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/treatment-of-dyslipoproteinemia-in-the-metabolic-syndrome\/","og_site_name":"Aprifel","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/treatment-of-dyslipoproteinemia-in-the-metabolic-syndrome\/","url":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/treatment-of-dyslipoproteinemia-in-the-metabolic-syndrome\/","name":"Treatment of dyslipoproteinemia in the metabolic syndrome - Aprifel","isPartOf":{"@id":"https:\/\/www.aprifel.com\/fr\/#website"},"datePublished":"2018-12-04T06:12:23+00:00","dateModified":"2018-12-04T06:12:23+00:00","description":"Treatment of dyslipoproteinemia in the metabolic syndrome - Aprifel","breadcrumb":{"@id":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/treatment-of-dyslipoproteinemia-in-the-metabolic-syndrome\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/treatment-of-dyslipoproteinemia-in-the-metabolic-syndrome\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/treatment-of-dyslipoproteinemia-in-the-metabolic-syndrome\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.aprifel.com\/fr\/"},{"@type":"ListItem","position":2,"name":"R\u00e9sum\u00e9s","item":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/"},{"@type":"ListItem","position":3,"name":"Treatment of dyslipoproteinemia in the metabolic syndrome"}]},{"@type":"WebSite","@id":"https:\/\/www.aprifel.com\/fr\/#website","url":"https:\/\/www.aprifel.com\/fr\/","name":"Aprifel","description":"Agence pour la Recherche et l\u2019Information en Fruits et L\u00e9gumes","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.aprifel.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/wp-json\/wp\/v2\/resume\/56178"}],"collection":[{"href":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/wp-json\/wp\/v2\/resume"}],"about":[{"href":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/wp-json\/wp\/v2\/types\/resume"}],"wp:attachment":[{"href":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/wp-json\/wp\/v2\/media?parent=56178"}],"wp:term":[{"taxonomy":"mots_cles","embeddable":true,"href":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/wp-json\/wp\/v2\/mots_cles?post=56178"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}